Insulin-like growth factor binding protein-5 modulates muscle differentiation through an insulin-like growth factor-dependent mechanism

The insulin-like growth factor binding proteins (IGFBPs) are a family of six secreted proteins which bind to and modulate the actions of insulin-like growth factors-I and -II (IGF-I and -II). IGFBP-5 is more conserved than other IGFBPs characterized to date, and is expressed in adult rodent muscle and in the developing myotome. We have shown previously that C2 myoblasts secrete IGFBP-5 as their sole IGFBP. Here we use these cells to study the function of IGFBP-5 during myogenesis, a process stimulated by IGFs. We stably transfected C2 cells with IGFBP- 5 cDNAs under control of a constitutively active promoter. Compared with vector-transfected control cells, C2 myoblasts expressing the IGFBP-5 transgene in the sense orientation exhibit increased IGFBP-5 levels in the extracellular matrix during proliferation, and subsequently fail to differentiate normally, as assessed by both morphological and biochemical criteria. Compared to controls, IGFBP-5 sense myoblasts show enhanced survival in low serum medium, remaining viable for at least four weeks in culture. By contrast, myoblasts expressing the IGFBP-5 antisense transcript differentiate prematurely and more extensively than control cells. The inhibition of myogenic differentiation by high level expression of IGFBP-5 could be overcome by exogenous IGFs, with des (1-3) IGF-I, an analogue with decreased affinity for IGFBP-5 but normal affinity for the IGF-I receptor, showing the highest potency. These results are consistent with a model in which IGFBP-5 blocks IGF-stimulated myogenesis, and indicate that sequestration of IGFs in the extracellular matrix could be a possible mechanism of action. Our observations also suggest that IGFBP-5 normally inhibits muscle differentiation, and imply a role for IGFBP-5 in regulating IGF action during myogenic development in vivo.

[1]  H. Weintraub,et al.  Expression of a single transfected cDNA converts fibroblasts to myoblasts , 1987, Cell.

[2]  C. Stewart,et al.  Insulin-like Growth Factor-II Is an Autocrine Survival Factor for Differentiating Myoblasts (*) , 1996, The Journal of Biological Chemistry.

[3]  T. Braun,et al.  A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts. , 1989, The EMBO journal.

[4]  H. Okayama,et al.  Calcium phosphate-mediated gene transfer: a highly efficient transfection system for stably transforming cells with plasmid DNA. , 1988, BioTechniques.

[5]  S. Rosenthal,et al.  Skeletal muscle cell-derived insulin-like growth factor (IGF) binding proteins inhibit IGF-I-induced myogenesis in rat L6E9 cells. , 1995, Endocrinology.

[6]  P. Rotwein,et al.  Rapid activation of insulin-like growth factor binding protein-5 gene transcription during myoblast differentiation. , 1995, Molecular endocrinology.

[7]  D. Melton,et al.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. , 1984, Nucleic acids research.

[8]  N. Bleehen,et al.  Diminished Expression of Insulin-like Growth Factor (IGF) Binding Protein-5 and Activation of IGF-I-mediated Autocrine Growth in Simian Virus 40-transformed Human Fibroblasts (*) , 1995, The Journal of Biological Chemistry.

[9]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[10]  F. Gros,et al.  Control of myogenesis in the mouse myogenic C2 cell line by medium composition and by insulin: characterization of permissive and inducible C2 myoblasts. , 1988, Differentiation; research in biological diversity.

[11]  J. Baker,et al.  Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r) , 1993, Cell.

[12]  T. Nam,et al.  Human fibroblasts secrete a serine protease that cleaves insulin-like growth factor-binding protein-5. , 1994, Endocrinology.

[13]  J. Milbrandt,et al.  Differential expression of insulin-like growth factor genes in rat central nervous system. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[14]  D. Clemmons,et al.  Insulin-like growth factors and their binding proteins: biological actions. , 1995, Endocrine reviews.

[15]  S. Rosenthal,et al.  Opposing early and late effects of insulin-like growth factor I on differentiation and the cell cycle regulatory retinoblastoma protein in skeletal myoblasts. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[16]  D. Clemmons,et al.  Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I , 1993, The Journal of cell biology.

[17]  P. Rotwein,et al.  A highly conserved insulin-like growth factor-binding protein (IGFBP-5) is expressed during myoblast differentiation. , 1993, The Journal of biological chemistry.

[18]  M. Rechler,et al.  Recombinant human insulin-like growth factor (IGF)-binding protein-6 inhibits IGF-II-induced differentiation of L6A1 myoblasts. , 1994, Endocrinology.

[19]  J. Florini,et al.  Paradoxical decrease in myf-5 messenger RNA levels during induction of myogenic differentiation by insulin-like growth factors. , 1992, Molecular endocrinology.

[20]  J. Florini,et al.  Highly specific inhibition of IGF-I-stimulated differentiation by an antisense oligodeoxyribonucleotide to myogenin mRNA. No effects on other actions of IGF-T. , 1990, The Journal of biological chemistry.

[21]  E. Olson,et al.  Helix-loop-helix proteins as regulators of muscle-specific transcription. , 1993, The Journal of biological chemistry.

[22]  J R Florini,et al.  "Spontaneous" differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II. , 1991, The Journal of biological chemistry.

[23]  M. Rechler.  Insulin-like growth factor binding proteins. , 1993, Vitamins and hormones.

[24]  R. Nachman,et al.  Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cells. , 1987, The Journal of clinical investigation.

[25]  J. Florini,et al.  IGF binding proteins-4, -5 and -6 may play specialized roles during L6 myoblast proliferation and differentiation. , 1995, The Journal of endocrinology.

[26]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[27]  J. Florini,et al.  Insulin-like growth factor-I stimulates terminal myogenic differentiation by induction of myogenin gene expression. , 1991, Molecular endocrinology.

[28]  T. Wirth,et al.  A strategy for efficient in vitro translation of cDNAs using the rabbit beta-globin leader sequence , 1991, Nucleic Acids Res..

[29]  E. Olson,et al.  A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program. , 1989, Genes & development.

[30]  M. Binoux,et al.  Identification of an insulin‐like growth factor‐binding protein in human cerebrospinal fluid with a selective affinity for IGF‐II , 1986, FEBS letters.

[31]  D. Clemmons,et al.  Identification of the forms of insulin-like growth factor-binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion. , 1992, The Journal of biological chemistry.

[32]  D. Bader,et al.  Immunochemical analysis of myosin heavy chains in the developing chicken heart. , 1984, Developmental biology.

[33]  A. Lassar,et al.  Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. , 1994, Current opinion in cell biology.

[34]  T. Wood,et al.  Distinct expression patterns of insulin-like growth factor binding proteins 2 and 5 during fetal and postnatal development. , 1994, Endocrinology.

[35]  D. Clemmons,et al.  Insulin‐like growth factor binding protein secretion by muscle cells: Effect of cellular differentiation and proliferation , 1988, Journal of cellular physiology.

[36]  J. Florini,et al.  Effects of growth factors on myogenic differentiation. , 1989, The American journal of physiology.

[37]  E. Olson.  Signal transduction pathways that regulate skeletal muscle gene expression. , 1993, Molecular endocrinology.

[38]  D. Clemmons,et al.  Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: effects on affinity for IGF-I. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[39]  P. Rotwein,et al.  Insulin-like growth factors (IGF) in muscle development. Expression of IGF-I, the IGF-I receptor, and an IGF binding protein during myoblast differentiation. , 1989, The Journal of biological chemistry.